Home/Filings/4/0001437749-13-002484
4//SEC Filing

Chiarelli Joseph 4

Accession 0001437749-13-002484

CIK 0001417663other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:37 PM ET

Size

5.8 KB

Accession

0001437749-13-002484

Insider Transaction Report

Form 4
Period: 2013-02-21
Chiarelli Joseph
DirectorChief Executive Officer
Transactions
  • Award

    Options

    2013-02-21+2,250,0002,250,000 total
    Exercise: $0.35Exp: 2018-02-21Common Stock, $0.001 par value (2,250,000 underlying)
Footnotes (1)
  • [F1]The options vest and become exercisable in five installments as follows: (i) 375,000 vested at grant; (ii) 375,000 vest upon the Company completing a financing resulting in gross proceeds to the Company of no less than $5.0 million at a price per share of not less than $0.35; (iii) 375,000 upon the execution by the Company of a license or distribution agreement from which the Company is entitled to receive gross proceeds of no less than $1.0 million and the Company has received payments of at least $250,000; (iv) 375,000 vest upon receipt by the Company of FDA approval for the use of dermaPACE; and (v) 750,000 vest in the event the Company achieves the milestones (i), (ii), (iii) and (iv) above during the initial two year term of Mr. Chiarelli's employment with the Company, and the term is not extended by the Company.

Issuer

SANUWAVE Health, Inc.

CIK 0001417663

Entity typeother

Related Parties

1
  • filerCIK 0001571016

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:37 PM ET
Size
5.8 KB